MORPHINE SULFATE IR 30 MG TAB

Morphine Sulfate
$0.3855per EA
DEA Schedule CII

Strength

30 mg/1

Manufacturer

SpecGx LLC

NDC

00406511901

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

MORPHINE SULFATE

Approval Type

Generic (ANDA)

FDA Application

ANDA215194

On Market Since

9/1/2023

Pharmacological Classes

Full Opioid Agonists
Opioid Agonist

Price History

1W

0.0%

1M

+1.4%

3M

-7.7%

6M

-13.4%

1Y

-4.0%

3Y

N/A

5Y

N/A

All

+1.1%